Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome

被引:348
作者
Luna, CM
Blanzaco, D
Niederman, MS
Matarucco, W
Baredes, NC
Desmery, P
Palizas, F
Menga, G
Rios, F
Apezteguia, C
机构
[1] Univ Buenos Aires, Hosp Clin Jose San Martin, Div Pulm, Dept Med, RA-1053 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Clin Jose San Martin, Crit Care Div, Dept Med, RA-1053 Buenos Aires, DF, Argentina
[3] Winthrop Univ Hosp, Div Pulm & Crit Care, Mineola, NY 11501 USA
[4] Sanatorio Otamendi Miroli, Crit Care Serv, Buenos Aires, DF, Argentina
[5] Sanatorio Mitre, Crit Care Serv, Buenos Aires, DF, Argentina
[6] Clin Bazterr, Crit Care Serv, Buenos Aires, DF, Argentina
[7] Hosp Maria Ferrer, Gobierno Autonoma Ciudad, Crit Care Serv, Buenos Aires, DF, Argentina
[8] Policlin Alejandro Posados, Crit Care Div, Haedo, Provincia Bueno, Argentina
关键词
ventilator-associated pneumonia; intensive care; infection;
D O I
10.1097/01.CCM.0000055380.86458.1E
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To prospectively evaluate the performance of the Clinical Pulmonary Infection Score (CPIS) and its components to identify early in the hospital course of ventilator-associated pneumonia (VAP) which patients are responding to therapy. Design: Prospective, multicenter, in a cohort of mechanically ventilated patients. Setting: The intensive care unit of six hospitals located in the metropolitan area of Buenos Aires, Argentina. Patients: Sixty-three patients, from a cohort of 472 mechanically ventilated patients hospitalized for >72 hrs, had clinical evidence of VAP and bacteriologic confirmation by bronchoalveolar lavage (BAL) or blood cultures. Interventions: Bronchoscopy with BAL fluid culture and blood cultures after establishing a clinical diagnosis of VAP. All patients received antibiotics, 46 before bronchoscopy and 17 immediately after bronchoscopy. Measurements and Results: CPIS was measured at 3 days before VAP (VAP-3); at the onset of VAP (VAP); and at 3 (VAP+3), 5 (VAP+5), and 7 (VAP+7) days after onset. CPIS rose from VAP-3 to VAP and then fell progressively in the population as a whole (p <.001), and the fall in CPIS was significant in 31 survivors, but not in 32 nonsurvivors. From the individual components of the CPIS, only the Pao(2)/Fio(2) ratio distinguished survivors from nonsurvivors, beginning at VAP+3. When CPIS was <6 at 3 or 5 days after VAP onset, mortality was lower than in the remaining patients (p =.018). These differences also related to the finding that those receiving adequate therapy bad a slight fall in CPIS and a significant increase of Pao(2)/Fio(2) at VAP+3, whereas those getting inadequate therapy did not. Conclusions: Serial measurements of CPIS can define the clinical course of VAP resolution, identifying those with good outcome as early as day 3, and could possibly be of help to define strategies to shorten the duration of therapy.
引用
收藏
页码:676 / 682
页数:7
相关论文
共 28 条
[11]   NOSOCOMIAL PNEUMONIA IN PATIENTS RECEIVING CONTINUOUS MECHANICAL VENTILATION - PROSPECTIVE ANALYSIS OF 52 EPISODES WITH USE OF A PROTECTED SPECIMEN BRUSH AND QUANTITATIVE CULTURE TECHNIQUES [J].
FAGON, JY ;
CHASTRE, J ;
DOMART, Y ;
TROUILLET, JL ;
PIERRE, J ;
DARNE, C ;
GIBERT, C .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (04) :877-884
[12]  
Fagon JY, 2000, PRESSE MED, V29, P2044
[13]  
GARRARD CS, 1995, CHEST, V108, pS15
[14]   Relationship between ventilator-associated pneumonia and intramucosal gastric pHi: A case-control study [J].
Hernandez, C ;
ElEbiary, M ;
Gonzalez, J ;
delaBellacasa, JP ;
Monton, C ;
Torres, A .
JOURNAL OF CRITICAL CARE, 1996, 11 (03) :122-128
[15]   The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient [J].
Heyland, DK ;
Cook, DJ ;
Griffith, L ;
Keenan, SP ;
Brun-Buisson, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1249-1256
[16]  
Kollef MH, 1998, NEW HORIZ-SCI PRACT, V6, P52
[17]   Inadequate antimicrobial treatment of infections - A risk factor for hospital mortality among critically ill patients [J].
Kollef, MH ;
Sherman, G ;
Ward, S ;
Fraser, VJ .
CHEST, 1999, 115 (02) :462-474
[18]   The influence of mini-BAL cultures on patient outcomes - Implications for the antibiotic management of ventilator-associated pneumonia [J].
Kollef, MH ;
Ward, S .
CHEST, 1998, 113 (02) :412-420
[19]  
Lowenkron S E, 1992, Semin Respir Infect, V7, P271
[20]   Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia [J].
Luna, CM ;
Vujacich, P ;
Niederman, MS ;
Vay, C ;
Gherardi, C ;
Matera, J ;
Jolly, EC .
CHEST, 1997, 111 (03) :676-685